K. Hanna

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis

Franz Fazekas, Fred Lublin, D. Li et al. · Neurology · 2008 · 117 citations

Life Sciences, Neurology, Pharmacotherapy +12

Vigorimeter grip strength in <scp>CIDP</scp>: a responsive tool that rapidly measures the effect of <scp>IVIG</scp> – the <scp>ICE</scp> study

Els K. Vanhoutte, Norman Latov, C. Q. Deng et al. · European Journal of Neurology · 2012 · 94 citations

Medicine, Neurology, Pharmacotherapy +13

Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance

Ingemar S.J. Merkies, S. I. van Nes, K. Hanna et al. · Journal of Neurology Neurosurgery & Psychiatry · 2010 · 84 citations

Life Sciences, Neurology, Pharmacotherapy +13

Health-related quality-of-life improvements in CIDP with immune globulin IV 10%

Ingemar S. J. Merkies, Vera Bril, Marinos C. Dalakas et al. · Neurology · 2009 · 62 citations

Life Sciences, Immunology, Neurology +14

Safety of catheter‐delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results

Victor J. Marder, Anthony J. Comerota, Richard D. Shlansky-Goldberg et al. · Journal of Thrombosis and Haemostasis · 2012 · 23 citations

Medicine, Surgery, Vascular Surgery +7